XENPOZYME subst sèche 4 mg flac
7680672870014
CH-67287
A16AB25
07.99.0.
1 / 3
google
Details
- Product number
- 6728702
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: olipudasum alfa 4 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, saccharum, methioninum, pro vitro corresp. natrium 0.6 mg.
Articles (1)
Xenpozyme 4 mg, poudre pour solution à diluer pour perfusion
Puder
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
4.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
0.6 MG | Substance | HBESI |
Authorization holder
Sanofi-Aventis (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 67287
- Drug name
- Xenpozyme, poudre pour solution à diluer pour perfusion
- Galenic form
- PULPI
- ATC Code
- A16AB25
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 19/12/2023
- Authorization expiration date
- 18/12/2028
- IT number
- 07.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- XENPOZYME subst sèche 4 mg flac
- Description (DE)
- XENPOZYME Trockensub 4 mg Durchstf
- Market launch
- 19/12/2023
- Narcotic (BTM)
- No